Source: BioCentury

EraCal Therapeutics: EraCal: fishing for new obesity targets

FEB 20, 2024 | 1:03 PM PST | BIOCENTURY | EMERGING COMPANY PROFILEERACAL: FISHING FOR NEW OBESITY TARGETSBY Swiss company's zebrafish platform identifies new appetite suppressant targets without unwanted adverse effectshttps://www.biocentury.com/article/651444/eracal-fishing-for-new-obesity-targets© 2024 BioCentury Inc. All Rights Reserved

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Josua Jordi's photo - Co-Founder & CEO of EraCal Therapeutics

Co-Founder & CEO

Josua Jordi

CEO Approval Rating

90/100

Read more